A study from Theratechnologies (the company behind Egrifta) analyzed 400 participants and found that among treatment responders, resolution of elevated triglycerides occurred in 17.5% compared to just 8% of non-responders (p=0.026)
Peptides enter circulation within 1530 minutes, producing a sharp plasma peak that research shows drops to sub-therapeutic levels within 3648 hours for small peptides under 2,000 daltons
This is about 100-fold greater than the rate reported for HIV
This means it can be legally purchased, possessed, and used for legitimate scientific research purposes, including in vitro studies, cell culture experiments, and approved animal research protocols
The six-monthly analysis revealed that the sperm parameters, including sperm motility (38 and 38 vs